On July 2, 2015, James J. McGorry, the executive vice president and general manager, Translational Oncology Solutions of Champions Oncology, Inc. resigned from the company.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
5.15 USD | +2.79% |
|
+6.19% | -8.36% |
![Consensus](/images/consensus_flch.gif)
1st Jan change | Capi. | |
---|---|---|
-8.36% | 68.1M | |
+19.45% | 44.48B | |
+44.19% | 40.57B | |
-8.57% | 38.82B | |
+33.72% | 32.22B | |
-8.34% | 27.84B | |
+16.23% | 26.79B | |
+48.30% | 14.31B | |
+35.70% | 12.7B | |
-7.21% | 11.23B |
- Stock Market
- Equities
- CSBR Stock
- News Champions Oncology, Inc.
- James J. McGorry Resigns as the Executive Vice President and General Manager, Translational Oncology Solutions of Champions Oncology, Inc